The schizophrenia market is on the cusp of a transformative era that will fundamentally redefine how this complex disorder is treated and managed. The convergence of long-acting injectable formulations, novel mechanisms of action, digital therapeutics, and precision psychiatry approaches is creating a new paradigm where treatment becomes more personalized, accessible, and effective. As we look...